[Clinical evaluation of Dumon stent for tracheobronchial stenosis due to advanced esophageal carcinoma].
We inserted Dumon stent to 13 patients with tracheobronchial stenosis due to advanced or recurrent esophageal carcinoma. Severe dyspnea was improved in 11 patients except for 2 patients with bilateral recurrent nerve palsy. 3 cases who had radiation therapy or chemotherapy lived over 150 days. We inserted esophageal stent in 4 cases. 2 patients died due to hemoptysis after 156 days and 35 days. We conclude that Dumon stent is one of the useful treatments in order to improve quality of life and prognosis of advanced or recurrent esophageal carcinoma.
Ohara
M
M
Division of Surgery, Keiyukai Sapporo Hospital, Japan.
Abe
T
T
Tanabe
Y
Y
Kusano
M
M
Kusumi
T
T
Okayasu
T
T
Hosokawa
M
M
D000368:Aged; D004938:Esophageal Neoplasms / Q000150:complications* / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local; D011788:Quality of Life; D015607:Stents; D014134:Tracheal Neoplasms / Q000473:pathology; D014135:Tracheal Stenosis / Q000209:etiology / Q000628:therapy*; D016896:Treatment Outcome